Skip to main content
Premium Trial:

Request an Annual Quote

Danaher to Offer 17.5 Million Shares in Public Offering

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher said after the close of the market on Monday that it plans on offering 17.5 million shares of its common stock in a public offering.

Danaher hasn't yet priced its offering, but the firm's shares closed Monday at $51.33 on the New York Stock Exchange.

It said that net proceeds will be used to pay a part of its $6.8 billion proposed purchase of Beckman Coulter, expected to close later this month. Proceeds also may be used for general corporate purposes if there are any remaining from the offering, or if the Beckman deal fails to close, Danaher said in a statement.

Citi, Morgan Stanley, Barclays Capital, and UBS Securities are acting as joint book-running managers. Baird, Jefferies, Banca IMI, Mitsubishi UFJ Securities, and Wells Fargo Securities are acting as co-managers.

In a document filed with the US Securities and Exchange Commission today, Danaher said it has granted the underwriters of the offering the option to purchase up to an additional 1.75 million shares at the public offering price.

The Scan

Dropped Charges

The US Justice Department has dropped visa fraud charges against five Chinese researchers, according to the Wall Street Journal.

More Kids

The Associated Press says Moderna is expanding its SARS-CoV-2 vaccine study to included additional children and may include even younger children.

PNAS Papers on Rat Clues to Human Migration, Thyroid Cancer, PolyG-DS

In PNAS this week: ancient rat genome analysis gives hints to human migrations, WDR77 gene mutations in thyroid cancer, and more.

Purnell Choppin Dies

Purnell Choppin, a virologist who led the Howard Hughes Medical Institute, has died at 91, according to the Washington Post.